Literature DB >> 7898298

Estimating diagnostic test accuracy using a "fuzzy gold standard".

C E Phelps1, A Hutson.   

Abstract

This study uses Monte Carlo methods to analyze the consequences of having a criterion standard ("gold standard") that contains some error when analyzing the accuracy of a diagnostic test using ROC curves. Two phenomena emerge: 1) When diagnostic test errors are statistically independent from inaccurate ("fuzzy") gold standard (FGS) errors, estimated test accuracy declines. 2) When the test and the FGS have statistically dependent errors, test accuracy can become overstated. Two methods are proposed to eliminate the first of these errors, exploring the risk of exacerbating the second. Both require a probabilistic (rather than binary) gold-standard statement (e.g., probability that each case is abnormal). The more promising of these, the "two-truth" method, selectively eliminates those cases where the gold standard is most ambiguous (probability near 0.5). When diagnostic test and FGS errors are independent, this approach can eliminate much of the downward bias caused by FGS error, without meaningful risk of overstating test accuracy. When the test and FGS have dependent errors, the resultant upward bias can cause test accuracy to be overstated, in the most extreme cases, even before the offsetting "two-truth" approach is employed.

Entities:  

Mesh:

Year:  1995        PMID: 7898298     DOI: 10.1177/0272989X9501500108

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  13 in total

1.  Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).

Authors:  Manfred Hauben; Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

2.  The meaning of the opposition between the healthy and the pathological and its consequences.

Authors:  Maël Lemoine
Journal:  Med Health Care Philos       Date:  2008-07-30

3.  Bayesian modeling for linking causally related observations in chest X-ray reports.

Authors:  W W Chapman; P J Haug
Journal:  Proc AMIA Symp       Date:  1998

Review 4.  Clinical application of DNA ploidy to cervical cancer screening: A review.

Authors:  David Garner
Journal:  World J Clin Oncol       Date:  2014-12-10

5.  Imperfect gold standards for biomarker evaluation.

Authors:  Sushrut S Waikar; Rebecca A Betensky; Sarah C Emerson; Joseph V Bonventre
Journal:  Clin Trials       Date:  2013-09-03       Impact factor: 2.486

6.  Thresholds and accuracy in screening tools for early detection of psychopathology.

Authors:  R Christopher Sheldrick; James C Benneyan; Ivy Giserman Kiss; Margaret J Briggs-Gowan; William Copeland; Alice S Carter
Journal:  J Child Psychol Psychiatry       Date:  2015-06-19       Impact factor: 8.982

7.  Imperfect gold standards for kidney injury biomarker evaluation.

Authors:  Sushrut S Waikar; Rebecca A Betensky; Sarah C Emerson; Joseph V Bonventre
Journal:  J Am Soc Nephrol       Date:  2011-10-21       Impact factor: 10.121

8.  Exceeding the limits of liver histology markers.

Authors:  Shruti H Mehta; Bryan Lau; Nezam H Afdhal; David L Thomas
Journal:  J Hepatol       Date:  2008-10-18       Impact factor: 25.083

9.  Diagnostic thresholds with three ordinal groups.

Authors:  Kristopher Attwood; Lili Tian; Chengjie Xiong
Journal:  J Biopharm Stat       Date:  2014       Impact factor: 1.051

10.  Follow-up after embolization of ruptured intracranial aneurysms: a prospective comparison of two-dimensional digital subtraction angiography, three-dimensional digital subtraction angiography, and time-of-flight magnetic resonance angiography.

Authors:  Zbigniew Serafin; Piotr Strześniewski; Władysław Lasek; Wojciech Beuth
Journal:  Neuroradiology       Date:  2012-04-10       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.